PER 3.49% 8.3¢ percheron therapeutics limited

You do realise where Roche paid $65M up-front mid Phase III...

  1. 35,692 Posts.
    lightbulb Created with Sketch. 552
    You do realise where Roche paid $65M up-front mid Phase III trial Chiasma had raised $38.5M to finish the Phase III a few months earlier & $21M the year before to get it underway right ?

    Funny what the number comes to when you take the Phase III funding out ?

    Always open to surprises though
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.3¢
Change
-0.003(3.49%)
Mkt cap ! $74.82M
Open High Low Value Volume
8.8¢ 8.8¢ 8.2¢ $46.49K 549.5K

Buyers (Bids)

No. Vol. Price($)
1 11758 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 24250 1
View Market Depth
Last trade - 16.10pm 10/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.